Efficacy and Safety of Oral Regimens for the Treatment of Chronic HCV Infection

NCT02202980 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

273

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: LDV/SOF
DRUG: RBV
DRUG: SOF/VEL
DRUG: VOX

Sponsor

Gilead Sciences